The cell-adhesion molecule L1 was originally described in the nervous system. It has recently been detected in CD4 T lymphocytes, peripheral B lymphocytes, and granulocytes in the human immune system and in similar leucocyte types in the murine immune system. L mediates neural recognition by Ca+z, Mg+2-independent homophilic binding. In the human and murine immune systems, L1 binds to the "classical" vitronectin receptor, ceV/33, and fibronectin receptor, ce5/31, respectively, and abstains from homophilic binding. Homophilic L1 binding probably involves antiparallel alignment of several interactive domains. Integrin binding is mediated by a short segment of immunoglobulinlike domain 6, which includes two RGD repeats in rodent L1 and one RGD motif in human L1. L1 is modulated in activated leucocytes in vitro in parallel to i-selectin, and diverse cell types release intact L in vivo and in vitro. Released L1 can bind to laminin and adheres to the extracellular matrix of sciatic nerve, M21 melanoma, and possibly spleen and other tissues. It can support integrin-dependent cell migration and preliminary data implicate it in tumor development and transnodal lymphocyte migration.
INTRODUCTION
The development of a functional cellular immune system and effective immune response depends on selective leucocyte trafficking to, from, and within organs of the immune system as well as to variable but specific addresses such as inflammatory sites.
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Correct leucocyte trafficking is mediated by contactdependent interactions between leucocytes and postcapillary endothelial cells, glandular stroma cells, and extracellular matrices. These interactions require multiple-adhesion mechanisms that can recognize appropriate targets and be modulated by the cell during recognition events. Intensive investigations of leucocyte extravasation have produced ample information on the mechanisms mediating leucocyteendothelial recognition (for extensive reviews, see Butcher, 1991; Imhof and Dunon, 1995) . There is, however, little information on the adhesion mechanisms that mediate leucocyte migration through and beyond the endothelial wall, through lymph glands and inflamed tissues.
During the last year, the cell-adhesion molecule L has emerged as an important candidate for mediating such processes. L1 is primarily expressed by neural and blood cells involved in targeted migration and is at present the only known cell-adhesion molecule that is abundant in both nervous and immune systems. Its importance in human ontogenesis is underlined by the severity of neurological disorders associated with mutations in the L1 gene. These include hydrocephalus and mental retardation and have recently been united under the acronym CRASH syndromes (Fransen et al., 1995) . Associated manifestations in the immune system remain to be defined.
In the nervous system, L1 is predominantly expressed by neuronal subsets and Schwann cells. It mediates neuronal adhesion, axonal navigation and fasciculation, axon-Schwann cell recognition, and possibly granule-cell migration. In the immune system, L1 is expressed by neutrophils and lymphocyte subsets (Table I) (Fig. 1B) . The HNK-1 epitope is involved in L1 binding to laminin (Hall et al., 1993) and ligand binding to P-and L-selectin (Needham and Schnaar, 1993; Sammar et al., 1994) , whereas the L3 glycan has been implicated in L1-NCAM cohesion in neurones (Horstkorte et al., 1993) . The expression of the HNK-1 and L3 epitopes by L1 in blood cells has not been studied.
L1 LIGANDS
The functional vicissitude of L has been attributed to its recently discovered diversity of binding mechanisms (Table II In the nervous system, L1 mediates neuronal recognition by temperature-and cation-independent homophilic binding (Lemmon et al., 1989) Fig. 2B and Fig. 2C) A5/31 strongly binds to murine (Ruppert et al., 1995) but not human (Ebeling et al., 1996) L1. Therefore, c5/31 possibly recognizes the fibronectinlike motif RGDS of rodent L1 (Fig. 2B ) that is missing in human L1. AV/33 appears to bind to the conserved RGDG site of L1 (Fig. 2B ), since M21 cell adhesion to human L1 is abolished by mutation of this motif (Montgomery et al., 1996) , and human cV/33 mediates cell binding to human, rat (Montgomery et Imhof and Dunon, 1995) . Among these, CD31 is of particular interest since L1 and CD31 appear to have similar homophilic binding mechanisms ( Fig. 2A ) and high affinity for ceV/33 (Piali et al., 1995; Montgomery et al., 1996) but are expressed by mutually exclusive lymphocyte subsets (Ebeling et al., 1996) . (Montgomery et al., 1996) . In addition, monoclonal L1 antibody 324 that specifically inhibits L1-integrin interactions does not perturb the short-term aggregation of murine cerebellar neurones and neuroblastoma N2A cells (Rathjen and Schachner, 1984) . But it inhibits the migration of granule-cell neurones (Lindner et al., 1983) and neurite elongation (Fischer et al., 1986) in cerebellar explants from postnatal mice. Moreover, homophilic L1 binding activates FGF receptor-dependent signal transduction in rat neurones, but probably not nonreceptor-type tyrosine kinases (Doherty et al., 1995) . However, neurite extension by murine cerebellar neurones on immobilized L1 is specifically abolished by homozygous src deletion (Ignelzi et al., 1994) (Montgomery et al., 1996) , and lymphocytes downregulate L1 expression upon activation in vitro and in vivo (Hubbe et al., 1993) . Stimulation of neutrophils with the phorbolester PMA leads to rapid loss of L1 from the cell surface with remarkably similar kinetics to the shedding of i-selectin. L-selectin shedding has recently been shown to depend on an MMPl-like metalloendoprotease (Preece et al., 1996) . Whether a similar mechanism also applies to L1 remains to be examined. Released L1 can be detected in association with the extracellular matrix of murine sciatic nerve (Martini and Schachner, 1986) , and within intratumor laminin strands of human melanoma M21 (Montgomery et al., 1986) . Selective binding between purified L1 and laminin has been demonstrated (Hall et al., 1993) , but the physiological function of matrixembedded L1 is still uncertain. Conceivably, matrixembedded L1 gradients may locally promote targeted cell migration as a substrate for integrin adhesion. Recent experiments using recombinant L1 have shown that L1 indeed can support integrin-mediated cell migration (Duzcmal et al., 1997) . The possibility that released L1 may promote intratumor angiogenesis by interaction with ceV integrins of sprouting vessels can also be considered.
CONCLUSIONS
The cell-adhesion molecule L1 serves both as a celladhesion molecule and as a matrix-embedded substrate for cell migration. In both functions, L1 may undergo homophilic interaction or bind to "classical" integrin-matrix receptors. Dual homophilic and integ-. rin binding has also been reported for the nonneural recognition molecules CD31 and E-cadherin. Homophilic binding has primarily been associated with early recognition events. Binding between homophilic cell-adhesion molecules and integrins appears to stabilize cell connections and promote cell motility. This information implies that the major difference between cell-cell and cell-matrix interactions pertain to early recognition and choice of contact. But the mechanisms mediating long-term adhesion and migration on cellular and matrix substrates may be related.
